London Daily

Focus on the big picture.
Saturday, Jul 05, 2025

Pfizer & AstraZeneca Covid-19 vaccines ‘highly effective’ in vulnerable people in UK, study of 1 million jab recipients finds

Pfizer & AstraZeneca Covid-19 vaccines ‘highly effective’ in vulnerable people in UK, study of 1 million jab recipients finds

The Covid-19 vaccines made by Oxford-AstraZeneca and Pfizer-BioNTech are just as effective in people with underlying conditions as the rest of the population, a UK study of one million participants has shown.
Last year the British government advised clinically extremely vulnerable people to stay at home – known as “shielding” – to protect themselves from the virus, before dropping its recommendation last month

Conditions including diabetes, severe asthma, and diseases that weaken the immune system – like blood cancer – have all been linked to an increased risk of hospitalisation or death from Covid-19.

On Friday, the government said a Public Health England (PHE) study had shown that people with such conditions are protected against symptomatic infection by two doses of the Pfizer or AstraZeneca vaccines – the UK’s most widely used Covid jabs.

The report, published in preprint format without being peer-reviewed, showed an efficacy of 60% among at-risk groups for either vaccine after one dose.

After a second dose, this rises to 81% for AstraZeneca among the ‘at risk’ 16-64 age cohort, PHE said in a statement.

For people in at-risk groups aged 65 and over, the efficacy is 89% for Pfizer and 80% with AstraZeneca.

For people with weakened immune systems, the efficacy for either jab after a first dose is only 4%, although this rises substantially to 74% after a second dose.

“This real-world data shows for the first time that most people who are clinically vulnerable to Covid-19 still receive high levels of protection after two doses of vaccine,” Dr Mary Ramsay, Head of Immunisation at PHE, said.

The study’s authors addressed the relatively low protection of 4% that one dose of the vaccines offers immunosuppressed people.

The result “stands out,” they said, but they added that once people with weakened immune systems get a second dose they would only see a “minor reduction in vaccine effectiveness” compared to people who aren’t clinically vulnerable.

In the UK, more than 86% of people have received a first dose of a Covid-19 vaccine, while 65% have received a second dose, according to the latest data from Thursday.

The government reduced the interval between doses for clinically vulnerable people from 12 to 8 weeks in May, and it now says everyone in this group should have been offered a second dose.
Newsletter

Related Articles

0:00
0:00
Close
London Stock Exchange Faces Historic Low in Initial Public Offerings
A new online platform has emerged in the United Kingdom, specifically targeting Muslim men seeking virgin brides
Trump Celebrates Independence Day with B-2 Flyover and Signs Controversial Legislation
Boris Johnson Urges Conservatives to Ignore Farage
SNP Ordered to Update Single-Sex Space Guidance Within Days
Starmer Set to Reject Calls for Wealth Taxes
Stolen Century-Old Rolls-Royce Recovered After Hotel Theft
Macron Presses Starmer to Recognise Palestinian State
Labour Delayed Palestine Action Ban Over Riot Concerns
Swinney’s Tax Comments ‘Offensive to Scots’, Say Tories
High Street Retailers to Enforce Bans on Serial Shoplifters
Music Banned by Henry VIII to Be Performed After 500 Years
Steve Coogan Says Working Class Is Being ‘Ethnically Cleansed’
Home Office Admits Uncertainty Over Visa Overstayer Numbers
JD Vance Questions Mandelson Over Reform Party’s Rising Popularity
Macron to Receive Windsor Carriage Ride in Royal Gesture
Labour Accused of ‘Hammering’ Scots During First Year in Power
BBC Head of Music Stood Down Amid Bob Vylan Controversy
Corbyn Eyes Hard-Left Challenge to Starmer’s Leadership
London Tube Trains Suspended After Major Fire Erupts Nearby
Richard Kemp: I Felt Safer in Israel Under Attack Than in the UK
Cyclist Says Police Cited Human Rights Act for Riding No-Handed
China’s Central Bank Consults European Peers on Low-Rate Strategies
AI Raises Alarms Over Long-Term Job Security
Saudi Arabia Maintains Ties with Iran Despite Israel Conflict
Musk Battles to Protect Tesla Amid Trump Policy Threats
Air France-KLM Acquires Majority Stake in Scandinavian Airlines
UK Educators Sound Alarm on Declining Child Literacy
Shein Fined €40 Million in France Over Misleading Discounts
Brazil’s Lula Visits Kirchner During Argentina House Arrest
Trump Scores Legislative Win as House Passes Tax Reform Bill
Keir Starmer Faces Criticism After Rocky First Year in Power
DJI Launches Heavy-Duty Coaxial Quadcopter with 80 kg Lift Capacity
U.S. Senate Approves Major Legislation Dubbed the 'Big Beautiful Bill'
Largest Healthcare Fraud Takedown in U.S. History Announced by DOJ
Poland Implements Border Checks Amid Growing Migration Tensions
Political Dispute Escalates Between Trump and Musk
Emirates Airline Expands Market Share with New $20 Million Campaign
Amazon Reaches Milestone with Deployment of One Millionth Robot
US Senate Votes to Remove AI Regulation Moratorium from Domestic Policy Bill
Yulia Putintseva Calls for Spectator Ejection at Wimbledon Over Safety Concerns
Jury Deliberations in Diddy Trial Yield Partial Verdict in Serious Criminal Charges
House Oversight Committee Subpoenas Former Jill Biden Aide Amid Investigation into Alleged Concealment of President Biden's Cognitive Health
King Charles Plans Significant Role for Prince Harry in Coronation
Two Chinese Nationals Arrested for Espionage Activities Against U.S. Navy
Amazon Reaches Major Automation Milestone with Over One Million Robots
Extreme Heat Wave Sweeps Across Europe, Hitting Record Temperatures
Meta Announces Formation of Ambitious AI Unit, Meta Superintelligence Labs
Robots Compete in Football Tournament in China Amid Injuries
Trump Administration Considers Withdrawal of Funding for Hospitals Providing Gender Treatment to Minors
×